Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Sitagliptin 100 mg tablets vs Januvia 100 mg in healthy Thai volunteers (fasting)
TCTR20210217006Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sitagliptin (2 arms), sponsored by Bio-innova. Planned start May 2021; status: not yet recruiting.
02
Drugs
sitagliptin
Beyond the preview
Go deeper on TCTR20210217006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210217006.